glycine has been researched along with Diabetic Angiopathies in 9 studies
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Glycine-treated diabetic rats showed an important diminution in the percentage of animals with opacity in lens and microaneurysms in the eyes." | 1.33 | Oral glycine administration attenuates diabetic complications in streptozotocin-induced diabetic rats. ( Alvarado-Vásquez, N; Carvajal-Sandoval, G; Cerón, E; Guevara, J; Lascurain, R; Montaño, LF; Tapia, A; Vanda, B; Zenteno, E, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chuĭko, MR | 1 |
| Efremova, NM | 1 |
| Skvortsova, VI | 1 |
| Reismann, P | 1 |
| Rosenson, RS | 1 |
| Wright, RS | 1 |
| Farkouh, M | 1 |
| Plutzky, J | 1 |
| Kimura, F | 1 |
| Hasegawa, G | 1 |
| Obayashi, H | 1 |
| Adachi, T | 1 |
| Hara, H | 1 |
| Ohta, M | 1 |
| Fukui, M | 1 |
| Kitagawa, Y | 1 |
| Park, H | 1 |
| Nakamura, N | 1 |
| Nakano, K | 1 |
| Yoshikawa, T | 1 |
| Alvarado-Vásquez, N | 1 |
| Lascurain, R | 1 |
| Cerón, E | 1 |
| Vanda, B | 1 |
| Carvajal-Sandoval, G | 1 |
| Tapia, A | 1 |
| Guevara, J | 1 |
| Montaño, LF | 1 |
| Zenteno, E | 1 |
| Liu, L | 1 |
| Xiang, K | 1 |
| Pulkkinen, A | 1 |
| Viitanen, L | 1 |
| Kareinen, A | 1 |
| Lehto, S | 1 |
| Laakso, M | 1 |
| Bilska, A | 1 |
| Włodek, L | 1 |
| Cruz, A | 1 |
| Moreau Lalande, H | 1 |
2 reviews available for glycine and Diabetic Angiopathies
| Article | Year |
|---|---|
Modulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects.
Topics: Alkanesulfonates; Diabetic Angiopathies; Glycine; Humans; Hypoglycemic Agents; Insulin Resistance; L | 2012 |
[Biologic properties of lipoic acid].
Topics: Acquired Immunodeficiency Syndrome; Aging; Animals; Antioxidants; Cataract; Decarboxylation; Diabeti | 2002 |
1 trial available for glycine and Diabetic Angiopathies
| Article | Year |
|---|---|
[Efficacy and safety of glycine and limontar in the complex therapy of discirculatory encephalopathy and encephalopathy in diabetes mellitus type I].
Topics: Cerebrovascular Disorders; Citrates; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Drug Combinat | 2010 |
6 other studies available for glycine and Diabetic Angiopathies
| Article | Year |
|---|---|
[Study of the Toll-like receptor 4 gene polymorphisms in diseases presenting with subclinical and chronic inflammation].
Topics: Alleles; Aspartic Acid; Brain Ischemia; Chronic Disease; Cytokines; Diabetes Complications; Diabetic | 2011 |
Serum extracellular superoxide dismutase in patients with type 2 diabetes: relationship to the development of micro- and macrovascular complications.
Topics: Amino Acid Substitution; Arginine; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angi | 2003 |
Oral glycine administration attenuates diabetic complications in streptozotocin-induced diabetic rats.
Topics: Administration, Oral; Aneurysm; Animals; Cerebral Arteries; Diabetes Mellitus, Experimental; Diabeti | 2006 |
RAGE Gly82Ser polymorphism in diabetic microangiopathy.
Topics: Amino Acid Substitution; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Gene Frequency; Genotype; | 1999 |
Gly82Ser polymorphism of the receptor of advanced glycation end product gene is not associated with coronary heart disease in Finnish nondiabetic subjects or in patients with type 2 diabetes.
Topics: Amino Acid Substitution; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; | 2000 |
Biochemical studies on glomerular basement membrane in human diabetic microangiopathy.
Topics: Amino Acids; Basement Membrane; Collagen; Diabetic Angiopathies; Glycine; Hexoses; Humans; Hydroxyly | 1978 |